BioNote Statistics

Total Valuation

BioNote has a market cap or net worth of KRW 516.94 billion. The enterprise value is 132.75 billion.

Market Cap	516.94B
Enterprise Value	132.75B

Important Dates

The last earnings date was Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

BioNote has 101.36 million shares outstanding. The number of shares has decreased by -0.38% in one year.

Current Share Class	101.36M
Shares Outstanding	101.36M
Shares Change (YoY)	-0.38%
Shares Change (QoQ)	-0.87%
Owned by Insiders (%)	58.09%
Owned by Institutions (%)	0.32%
Float	14.53M

Valuation Ratios

The trailing PE ratio is 12.24.

PE Ratio	12.24
Forward PE	n/a
PS Ratio	4.88
PB Ratio	0.32
P/TBV Ratio	0.32
P/FCF Ratio	15.06
P/OCF Ratio	10.88
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.17, with an EV/FCF ratio of 3.87.

EV / Earnings	3.13
EV / Sales	1.25
EV / EBITDA	3.17
EV / EBIT	3.95
EV / FCF	3.87

Financial Position

The company has a current ratio of 11.56, with a Debt / Equity ratio of 0.00.

Current Ratio	11.56
Quick Ratio	10.69
Debt / Equity	0.00
Debt / EBITDA	0.18
Debt / FCF	0.11
Interest Coverage	52.02

Financial Efficiency

Return on equity (ROE) is 2.66% and return on invested capital (ROIC) is 0.53%.

Return on Equity (ROE)	2.66%
Return on Assets (ROA)	0.51%
Return on Invested Capital (ROIC)	0.53%
Return on Capital Employed (ROCE)	0.81%
Revenue Per Employee	355.43M
Profits Per Employee	142.20M
Employee Count	298
Asset Turnover	0.06
Inventory Turnover	1.99

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +23.79% in the last 52 weeks. The beta is 1.11, so BioNote's price volatility has been higher than the market average.

Beta (5Y)	1.11
52-Week Price Change	+23.79%
50-Day Moving Average	4,679.60
200-Day Moving Average	4,736.50
Relative Strength Index (RSI)	70.13
Average Volume (20 Days)	92,774

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioNote had revenue of KRW 105.92 billion and earned 42.38 billion in profits. Earnings per share was 416.76.

Revenue	105.92B
Gross Profit	53.53B
Operating Income	13.47B
Pretax Income	56.39B
Net Income	42.38B
EBITDA	21.75B
EBIT	13.47B
Earnings Per Share (EPS)	416.76

Full Income Statement

Balance Sheet

The company has 388.06 billion in cash and 3.87 billion in debt, giving a net cash position of 384.19 billion or 3,790.28 per share.

Cash & Cash Equivalents	388.06B
Total Debt	3.87B
Net Cash	384.19B
Net Cash Per Share	3,790.28
Equity (Book Value)	1.62T
Book Value Per Share	15,990.55
Working Capital	422.63B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 47.51 billion and capital expenditures -13.19 billion, giving a free cash flow of 34.32 billion.

Operating Cash Flow	47.51B
Capital Expenditures	-13.19B
Free Cash Flow	34.32B
FCF Per Share	338.64

Full Cash Flow Statement

Margins

Gross margin is 50.54%, with operating and profit margins of 12.72% and 40.01%.

Gross Margin	50.54%
Operating Margin	12.72%
Pretax Margin	53.24%
Profit Margin	40.01%
EBITDA Margin	20.54%
EBIT Margin	12.72%
FCF Margin	32.41%

Dividends & Yields

This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 3.92%.

Dividend Per Share	200.00
Dividend Yield	3.92%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	48.17%
Buyback Yield	0.38%
Shareholder Yield	4.30%
Earnings Yield	8.20%
FCF Yield	6.64%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioNote has an Altman Z-Score of 5.06.

Altman Z-Score	5.06
Piotroski F-Score	n/a